Centers for Biologics Evaluation and Research

The Centers for Biologics Evaluation and Research (CBER) is a part of the U.S. Food and Drug Administration (FDA). It is responsible for ensuring the safety, effectiveness, and quality of biological products, which include vaccines, blood products, and cell therapies. CBER reviews new products, conducts research, and monitors their use to protect public health. By regulating these biologics, CBER plays a crucial role in preventing diseases and ensuring that treatments are safe and beneficial for patients.